Systems biology of coagulation initiation: Kinetics of thrombin generation in resting and activated human blood

PLoS Computational Biology

Volumn 6, Issue 9, 2010, Pages

  Chatterjee, Manash S ^a   Denney, William S ^a   Jing, Huiyan ^a   Diamond, Scott L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; ENZYMES; KINETIC PARAMETERS; KINETIC THEORY; ORDINARY DIFFERENTIAL EQUATIONS; SULFUR COMPOUNDS; TISSUE;

BLEEDINGS; BLOOD FUNCTIONS; CLINICAL INTERVENTIONS; HUMAN BLOODS; IN-VITRO; KINETIC MODELS; PLATELET ACTIVATORS; SYSTEMS BIOLOGY; THROMBIN GENERATION; TISSUE FACTORS;

PLATELETS;

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 9A; CATHEPSIN G; CITRIC ACID; CONVULXIN; FIBRINOGEN; GLYCOPROTEIN IB; PADGEM PROTEIN; PHOSPHATIDYLSERINE; PROTEIN DISULFIDE ISOMERASE; PUROMYCIN; THROMBIN; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FIBRIN FORMATION; FIBRIN POLYMERIZATION; HUMAN; IN VITRO STUDY; PHLEBOTOMY; PLATELET MICROPARTICLE; PROTEIN EXPRESSION; SYSTEMS BIOLOGY; THROMBIN TIME; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

ZEA MAYS;

EID: 78049416033     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1000950     Document Type: Article

References (93)

1. Rand MD, Lock JB, van't Veer C, Gaffney DP, Mann KG (1996) Blood clotting in minimally altered whole blood. Blood 88: 3432-3445.
2. Orfeo T, Butenas S, Brummel-Ziedins KE, Mann KG (2005) The tissue factor requirement in blood coagulation. J Biol Chem 280: 42887-42896.
3. Giesen PLA, Rauch U, Bohrmann B, Kling D, Roque M, et al. (1999) Blood-borne tissue factor: Another view of thrombosis. Proc Natl Acad Sci U S A 96: 2311-2315.
4. Butenas S, Orfeo T, Mann KG (2009) Tissue Factor in Coagulation: Which? Where? When? Arterioscler Thromb Vasc Biol 29: 1989-1996.
5. Panes O, Matus V, Saez CG, Quiroga T, Pereira J, et al. (2007) Human platelets synthesize and express functional tissue factor. Blood 109: 5242-5250.
6. Bach RR (2006) Tissue Factor Encryption. Arterioscler Thromb Vasc Biol 26: 456-461.
7. Morrissey JH, Pureza V, Davis-Harrison RL, Sligar SG, Ohkubo YZ, et al. (2008) Blood clotting reactions on nanoscale phospholipid bilayers. Thromb Res 122: S23-S26.
8. Bauer KA, Goodman TL, Kass BL, Rosenberg RD (1985) Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency. J Clin Invest 76: 826-836.
9. Cardigan RA, Crook M, Mackie IJ, Machin SJ (2001) Plasma levels of factor XIIa and factor VIIa are increased but not related in primary hyperlipidaemia. Blood Coagul Fibrinolysis 12: 187-192.
10. Nossel HL, Yudelman I, Canfield RE, Butler VP, Jr., Spanondis K, et al. (1974) Measurement of fibrinopeptide A in human blood. J Clin Invest 54: 43-53.
11. Shifman MA, Pizzo SV (1982) The in vivo metabolism of antithrombin III and antithrombin III complexes. J Biol Chem 257: 3243-3248.
12. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S (1990) Surface-Dependent Reactions of the Vitamin-K-Dependent Enzyme Complexes. Blood 76: 1-16.
13. Hemker HC (2008) Recollections on thrombin generation. J Thromb Haemost 6: 219-226.
14. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, et al. (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiology of Haemostasis and Thrombosis 33: 4-15.
15. Butenas S, Mann KG (2007) Caution in the interpretation of continuous thrombin generation assays. J Thromb Haemost 5: 1084-1085.
16. Mann KG, Whelihan MF, Butenas S, Orfeo T (2007) Citrate anticoagulation and the dynamics of thrombin generation. J Thromb Haemost 5: 2055-2061.
17. Hojima Y, Pierce JV, Pisano JJ (1980) Hageman factor fragment inhibitor in corn seeds: Purification and characterization. Thromb Res 20: 149-162.
18. Hockin MF, Jones KC, Everse SJ, Mann KG (2002) A model for the stoichiometric regulation of blood coagulation. J Biol Chem 277: 18322-18333.
19. Lo K, Denney WS, Diamond SL (2005) Stochastic modeling of blood coagulation initiation. Pathophysiol Haemost Thromb 34: 80-90.
20. Kuharsky AL, Fogelson AL (2001) Surface-Mediated Control of Blood Coagulation: The Role of Binding Site Densities and Platelet Deposition. Biophys J 80: 1050-1074.
21. Luan D, Zai M, Varner JD (2007) Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategies. Plos Comput Biol 3: 1347-1359.
22. Hemker HC, De Smedt E (2007) Caution in the interpretation of continuous thrombin generation assays: a rebuttal. J Thromb Haemost 5: 1085-1087.
23. Gosalia DN, Denney WS, Salisbury CM, Ellman JA, Diamond SL (2006) Functional phenotyping of human plasma using a 361-fluorogenic substrate biosensing microarray. Biotechnol Bioeng.
24. Mann KG, Brummel K, Butenas S (2003) What is all that thrombin for? J Thromb Haemost 1: 1504-1514.
25. Van Veen JJ, Gatt A, Cooper PC, Kitchen S, Bowyer AE, et al. (2008) Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters. Blood Coagul Fibrinolysis 19: 183-189.
26. del Conde I, Nabi F, Tonda R, Thiagarajan P, Lopez JA, et al. (2005) Effect of P-Selectin on Phosphatidylserine Exposure and Surface-Dependent Thrombin Generation on Monocytes. Arterioscler Thromb Vasc Biol 25: 1065-1070.
27. Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, et al. (1994) P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A 91: 8767-8771.
28. Polgar J, Matuskova J, Wagner DD (2005) The P-selectin, tissue factor, coagulation triad. J Thromb Haemost 3: 1590-1596.
29. Dougald MM, Maureane H, Julie AO, Harold RR (1997) Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 99: 542-547.
30. Weeterings C, de Groot PG, Adelmeijer J, Lisman T (2008) The glycoprotein Ib- IX-V complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface. Blood 112: 3227-3233.
31. Chen K, Lin Y, Detwiler TC (1992) Protein disulfide isomerase activity is released by activated platelets. Blood 79: 2226-2228.
32. Chen VM, Ahamed J, Versteeg HH, Berndt MC, Ruf W, et al. (2006) Evidence for Activation of Tissue Factor by an Allosteric Disulfide Bond. Biochemistry 45: 12020-12028.
33. Reinhardt C (2008) Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest 118: 1110-1122.
34. Pendurthi UR, Ghosh S, Mandal SK, Rao LVM (2007) Tissue factor activation: is disulfide bond switching a regulatory mechanism? Blood 110: 3900-3908.
35. Plescia J, Altieri DC (1996) Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. Biochem J 319: 873-879.
36. Schwertz H, Tolley ND, Foulks JM, Denis MM, Risenmay BW, et al. (2006) Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets. J Exp Med 203: 2433-2440.
37. Karas SP, Rosse WF, Kurlander RJ (1982) Characterization of the IgG-Fc receptor on human platelets. Blood 60: 1277-1282.
38. von dem Borne PA, Meijers JC, Bouma BN (1995) Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 86: 3035-3042.
39. Okorie UM, Denney WS, Chatterjee MS, Neeves KB, Diamond SL (2008) Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow. Blood 111: 3507-3513.
40. Fogelson AL, Tania N (2005) Coagulation under flow: the influence of flowmediated transport on the initiation and inhibition of coagulation. Pathophysiol Haemost Thromb 34: 91-108.
41. Camire RM, Pollak ES, Kaushansky K, Tracy PB (1998) Secretable human platelet-derived factor V originates from the plasma pool. Blood 92: 3035-3041.
42. Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, et al. (1992) Measurement of Basal Levels of Factor-Viia in Hemophilia-a and Hemophilia-B Patients. Blood 80: 25-28.
43. Macik BG, Hohneker J, Roberts HR, Griffin AM (1989) Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor. Am J Hematol 32: 232-234.
44. Bouma BN, Griffin JH (1977) Human-Blood Coagulation Factor-Xi - Purification, Properties, and Mechanism of Activation by Activated Factor- Xii. J Biol Chem 252: 6432-6437.
45. Naito K, Fujikawa K (1991) Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 266: 7353-7358.
46. Kramoroff A, Nigretto JM (2001) In vitro factor XI activation mechanism according to an optimized model of activated partial thromboplastin time test. Blood Coagul Fibrinolysis 12: 289-299.
47. Naski MC, Shafer JA (1991) A kinetic model for the alpha-thrombin-catalyzed conversion of plasma levels of fibrinogen to fibrin in the presence of antithrombin III. J Biol Chem 266: 13003-13010.
48. De Smedt E, Wagenvoord R, Hemker HC (2009) The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution. Thromb Haemost 101: 165-170.
49. Butenas S, Orfeo T, Gissel MT, Brummel KE, Mann KG (2004) The Significance of Circulating Factor IXa in Blood. J Biol Chem 279: 22875-22882.
50. Xu Z, Lioi J, Mu J, Kamocka MM, Liu X, et al. A Multiscale Model of Venous Thrombus Formation with Surface-Mediated Control of Blood Coagulation Cascade. 98: 1723-1732.
51. Purvis JE, Chatterjee MS, Brass LF, Diamond SL (2008) A molecular signaling model of platelet phosphoinositide and calcium regulation during homeostasis and P2Y1 activation. Blood 112: 4069-4079.
52. Butenas S, Mann KG (2004) Active tissue factor in blood? Nat Med 10: 1155-1156.
53. Hazegh-Azam M, Kim SS, Masoud S, Andersson L, White F, et al. (1998) The corn inhibitor of activated hageman factor: Purification and properties of two recombinant forms of the protein. Protein Expression and Purification 13: 143-149.
54. Sanchez J, Elgue G, Riesenfeld J, Olsson P (1998) Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin. Thromb Res 89: 41-50.
55. Revak SD, Cochrane CG, Bouma BN, Griffin JH (1978) Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma. J Exp Med 147: 719-729.
56. Back J, Lang MH, Elgue G, Kalbitz M, Sanchez J, et al. (2009) Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces. Biomaterials 30: 6573-6580.
57. Chatterjee MS, Purvis JE, Brass LF, Diamond SL Pairwise agonist scanning predicts cellular signaling responses to combinatorial stimuli. Nat Biotech 28: 727-732.
58. Brummel KE, Paradis SG, Branda RF, Mann KG (2001) Oral anticoagulation thresholds. Circulation 104: 2311-2317.
59. Schmidt H, Jirstrand M (2006) Systems Biology Toolbox for MATLAB: a computational platform for research in systems biology. Bioinformatics 22: 514-515.
60. Andersen H, Greenberg DL, Fujikawa K, Xu W, Chung DW, et al. (1999) Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. Proc Natl Acad Sci U S A 96: 11189-11193.
61. Bach R, Gentry R, Nemerson Y (1986) Factor-VII Binding to Tissue Factor in Reconstituted Phospholipid-Vesicles - Induction of Cooperativity by Phosphatidylserine. Biochemistry 25: 4007-4020.
62. O'Brien DP, Kemball-Cook G, Hutchinson AM, Martin DM, Johnson DJ, et al. (1994) Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q). Biochemistry 33: 14162-14169.
63. Shaw AW, Pureza VS, Sligar SG, Morrissey JH (2007) The local phospholipid environment modulates the activation of blood clotting. J Biol Chem 282: 6556-6563.
64. Baugh RJ, Broze GJ, Jr., Krishnaswamy S (1998) Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. J Biol Chem 273: 4378-4386.
65. Hathcock JJ, Rusinova E, Gentry RD, Andree H, Nemerson Y (2005) Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions. Biochemistry 44: 8187-8197.
66. Beals JM, Castellino FJ (1986) The Interaction of Bovine Factor-IX, Its Activation Intermediate, Factor-IX-Alpha, and Its Activation Products, Factor- IXa-Alpha and Factor-IXa-Beta, with Acidic Phospholipid-Vesicles of Various Compositions. Biochem J 236: 861-869.
67. Jenkins PV, Dill JL, Zhou Q, Fay PJ (2004) Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase. Biochemistry 43: 5094-5101.
68. Neuenschwander P, Jesty J (1988) A comparison of phospholipid and platelets in the activation of human factor VIII by thrombin and factor Xa, and in the activation of factor X. Blood 72: 1761-1770.
69. Rawala-Sheikh R, Ahmad SS, Ashby B, Walsh PN (1990) Kinetics of coagulation factor X activation by platelet-bound factor IXa. Biochemistry 29: 2606-2611.
70. Fay PJ, Smudzin TM (1992) Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa. J Biol Chem 267: 13246-13250.
71. Fay PJ, Mastri M, Koszelak ME (2001) Factor VIIIa cofactor activity shows enhanced ionic strength sensitivity in the absence of phospholipid. Biochim Biophys Acta 1548: 159-168.
72. Lindhout T, Goversriemslag JWP, Vandewaart P, Hemker HC, Rosing J (1982) Factor-Va Factor-Xa Interaction - Effects of Phospholipid-Vesicles of Varying Composition. Biochemistry 21: 5494-5502.
73. Rosing J, Tans G, Goversriemslag JWP, Zwaal RFA, Hemker HC (1980) Role of Phospholipids and Factor-Va in the Prothrombinase Complex. J Biol Chem 255: 274-283.
74. Huang ZF, Wun TC, Broze GJ (1993) Kinetics of Factor-Xa Inhibition by Tissue Factor Pathway Inhibitor. J Biol Chem 268: 26950-26955.
75. Tankersley DL, Finlayson JS (1984) Kinetics of activation and autoactivation of human factor XII. Biochemistry 23: 273-279.
76. Griep MA, Fujikawa K, Nelsestuen GL (1985) Binding and activation properties of human factor XII, prekallikrein and derived peptides with acidic lipid vesicles. Biochemistry 24: 4124-4130.
77. Inger S (1988) Inositolphospholipid-accelerated activation of prekallikrein by activated factor XII and its inhibition by β2-glycoprotein I. Eur J Biochem 176: 629-636.
78. Walsh PN, Griffin JH (1981) Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI. Blood 57: 106-118.
79. Tans G, Rosing J, Berrettini M, Lã{currency sign}mmle B, Griffin JH (1987) Autoactivation of human plasma prekallikrein. J Biol Chem 262: 11308-11314.
80. van der Graaf F, Koedam JA, Bouma BN (1983) Inactivation of kallikrein in human plasma. J Clin Invest 71: 149-158.
81. Pixley RA, Schapira M, Colman RW (1985) The Regulation of Human Factor- Xiia by Plasma Proteinase-Inhibitors. J Biol Chem 260: 1723-1729.
82. Gailani D, Broze GJ, Jr. (1991) Factor XI activation in a revised model of blood coagulation. Science 253: 909-912.
83. Oliver JA, Monroe DM, Roberts HR, Hoffman M (1999) Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol 19: 170-177.
84. Wuillemin WA, Eldering E, Citarella F, de Ruig CP, ten Cate H, et al. (1996) Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa. J Biol Chem 271: 12913-12918.
85. Walsh PN, Bradford H, Sinha D, Piperno JR, Tuszynski GP (1984) Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX. J Clin Invest 73: 1392-1399.
86. Gailani D, Ho D, Sun MF, Cheng QF, Walsh PN (2001) Model for a factor IX activation complex on blood platelets: dimeric conformation of factor IXa is essential. Blood 97: 3117-3122.
87. Scandura JM, Walsh PN (1996) Factor X Bound to the Surface of Activated Human Platelets Is Preferentially Activated by Platelet-Bound Factor IXa†Biochemistry 35: 8903-8913.
88. Wilkinson FH, Ahmad SS, Walsh PN (2002) The Factor IXa Second Epidermal Growth Factor (EGF2) Domain Mediates Platelet Binding and Assembly of the Factor X Activating Complex. J Biol Chem 277: 5734-5741.
89. Leipold RJ, Bozarth TA, Racanelli AL, Dicker IB (1995) Mathematical Model of Serine Protease Inhibition in the Tissue Factor Pathway to Thrombin. J Biol Chem 270: 25383-25387.
90. Lollar P, Knutson GJ, Fass DN (1985) Activation of porcine factor VIII:C by thrombin and factor Xa. Biochemistry 24: 8056-8064.
91. Komiyama Y, Pedersen AH, Kisiel W (1990) Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor. Biochemistry 29: 9418-9425.
92. Colman RW, Schmaier AH (1997) Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes. Blood 90: 3819-3843.
93. Colman R, Hirsh J, Marder V, Clowes A, George J (2001) Hemostasis and Thrombosis: Lippincott Williams and Wilkins.